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One route by  which Chlamydia  trachomatis is inter- 
nalized into host endometrial epithelial cells is receptor- 
mediated  endocytosis.  Although t is implies an adhesin- 
receptor interaction exists,  specific  chlamydial surface 
molecules  have  not  been  identified. We are investigating 
potential adhesin molecules  using an in  vitro functional 
assay to select  for  chlamydial  recombinant Escherichia 
coli expressing an  adherent phenotype. We have previ- 
ously  shown that E. coli JM109(pPBW58) attaches to epi- 
thelial cells by a specific  process paralleling c. tracho- 
matis and expresses at least three plasmid-encoded 
proteins (18,28, and 82  kDa; Schmiel, D. H., Knight, S. T., 
Raulston, J. E., Choong, J., Davis, C. H., and Wyrick, P. B. 
(1991) Infect.  Zmnun. 59, 40014012). In this report, we 
demonstrate that  (i)  the 82-kDa protein is associated 
with the outer membrane of both E. coli JM109- 
(pPBW58) and C. trachomatis serovar E elementary  bod- 
ies; (ii) the plasmid-encoded protein is identical to the 
native chlamydial protein by  mass, charge,  antigenicity, 
and partial proteolytic peptide profiles; (iii) a highly  ho- 
mologous protein is present in C. trachomatis biovari- 
ant lymphogranuloma  venereum; (iv) the 82-kDa protein 
is not  covalently  linked by disulfide  bonds to other pro- 
tein species in either E. coli JM109(pPBW58) or C. tra- 
chornatis; (v) sequence analysis of the open reading 
frame indicates this protein is a relative of the heat 
shock 70 family of proteins; and (vi) the inferred amino 
acid  sequence contains a contiguous  73-amino  acid re- 
gion  having 51% identity with the extracellular sperm 
receptor binding  domain in Strongylocentrosus purpu- 
ratus (Foltz, K. R., Partin, J. S., and Lennarz, W. J. (1993) 
Science 259,1421-1425). The potential involvement of an 
hsp70 protein in attachment may provide new insight on 
adherence mechanisms by obligate intracellular patho- 
gens. 
The chlamydiae are amazingly adept, obligate intracellular 
bacterial  pathogens  and  are responsible for a  broad spectrum of 
infectious disease syndromes in a variety of mammalian  and 
avian hosts.  One distinct subpopulation, isolates of Chlamydia  
trachomatis serovars D-K, causes epidemic sexually transmit- 
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ted infections in  the  United  States  and Europe (1). Often  asso- 
ciated  with genital inflammatory  syndromes such  as cervicitis, 
endometritis, salpingitis, urethritis, and epididymitis, chla- 
mydial infections can lead to  sterility  and ectopic pregnancy (2). 
These infections also account for one-fourth to one-half of the 
estimated 1,000,000 cases of pelvic inflammatory  disease in  the 
United States per year (3, 4). For such a predominant and 
costly pathogen, our knowledge of the basic mechanisms for 
establishment,  as well as eradication, of the infectious disease 
process is severely  limited. Although a wealth of information 
exists defining the chlamydial  developmental cycle at  a mor- 
phological level, surprisingly  little  is understood  about  patho- 
genicity at  a molecular level. The exclusive intracellular habi- 
tat of the chlamydiae has, to date, prevented the development 
of either a cell-free culture system or a genetic system for 
investigative  purposes. Thus,  the majority of our present 
knowledge about  the chlamydiae has been generated  through 
in vitro cell culture. 
These organisms exhibit two distinct morphologic forms. 
Outside of the eucaryotic  host cell, the infectious form is  termed 
an  elementary body (EB1.l EB are highly condensed,  metaboli- 
cally inert particles having a highly ordered chromosomal ar- 
rangement indicative of the absence of replicational, transcrip- 
tional  and  translational activity (5). Although the chlamydiae 
are Gram-negative bacteria,  having both inner  and  outer mem- 
brane  structures (6), the envelope has  several  unique  features 
including the absence of a peptidoglycan layer (7,  8 )  and clus- 
ters of macromolecular organelles called surface projections (6). 
Structural  stability of EB is  thought to be maintained by ex- 
tensive disulfide cross-linking of predominant, cysteine-rich 
outer  membrane  proteins (9, 10). Following internalization of 
EB by a  recipient  host cell, an unknown  signal triggers EB to 
convert into the larger, metabolically active reticulate body 
(RB) form. The cross-linked outer  membrane proteins are  re- 
duced to monomeric components (10, 11), the envelope becomes 
more fluid (121, and  transcription  and  translation proceed as 
RB expand and eventually divide by binary fission within a 
protective membrane-bound environment. The mechanism(s) 
by which chlamydia escape endosomal acidification or endo- 
somal-lysosomal fusion are unknown (13-15), although  heat- 
sensitive envelope proteins are likely mediators (15). Within 
* The abbreviations used are: EB, elementary body; RB, reticulate 
body; MOMP, major outer  membrane  protein; LGV, lymphogranuloma 
venereum;  hsp70,  heat shock protein 70; PVDF,  polyvinylidene  difluo- 
galactopyranoside; IPTG, isopropyl P-o-thiogalactopyranoside; LB, 
ride; DEAE, diethylaminoethyl; X-gal, 5-bromo-4-chloro-3-indolyl-~-~- 
Luna broth; PBS,  phosphate-buffered  saline;  PMSF,  phenylmethylsul- 
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23139 
This is an Open Access article under the CC BY license.
23140 C. trachomatis hsp7O Protein in Outer  Membrane 
this membrane-bound  environment, termed  an ''inclusion," the 
growing RB progeny parasitize  the host cell for ATP (16), cer- 
tain  essential amino acids (17), and metabolic cofactors (18). 
Presumably, once host cell nutrients  and metabolites become 
restricted or depleted, the chlamydial progeny convert back to 
the EB form, which are  subsequently released into  the envi- 
ronment  to  repeat  the infectious cycle. 
Specific molecules that  mediate  the interaction between EB 
and a recipient host cell, to initiate infection, have not been 
clearly defined. It is likely that multiple mechanisms exist, 
considering that various internalization  routes have been iden- 
tified. Some mechanisms for uptake may reflect the  nature of 
the  target cell (epithelial uersus fibroblast); other  routes may 
simply reflect the in vitro method of inoculation (19). The major 
outer  membrane protein (MOMP), which is a conserved protein 
among Chlamydia with  four antigenic variable  domains,  rep- 
resents approximately 60% of the  total protein composition of 
the outer membrane (20). This molecule, perhaps the most 
extensively studied,  contributes  to  the  attachment process by 
an electrostatic  mechanism of overcoming the  net negative sur- 
face charges between the  host cell and EB  (21). However, the 
interaction of MOMP with a specific receptor has not been 
defined. Another proposal for attachment involves a trimolecu- 
lar  event between  unknown  chlamydial and eucaryotic recep- 
tors with a specific glycosaminoglycan, heparan  sulfate,  serv- 
ing  as  the bridging molecule (22). Whether or not MOMP and 
heparan sulfate function together or separately, or involve 
other molecules for attachment,  is unknown. 
We have reported the binding and  entry of chlamydial  EB by 
receptor-mediated endocytosis (23-25). With the implication of 
a  receptor-adhesin interaction, we extended our  studies by gen- 
erating a C. trachomatis serovar E library in the surrogate 
genetic  host Escherichia coli JM109  and examined the ability of 
individual  recombinants to  attach  to  human  endometrial epi- 
thelial cells (26). E. coli JM109 (pPBW58), having a  contiguous 
6.7-kb chlamydial insert  in vector pUC19, expresses at least 
three chlamydial proteins (18, 28, and approximately  82 kDa) 
and attaches to epithelial cells in a highly specific manner, 
parallel to chlamydial EB. 
Our  current  studies involve characterization of each chla- 
mydial protein at the primary molecular level. Additionally, 
with the  potential for participation  in  an  attachment mecha- 
nism, each  protein is examined for association  with the  outer 
membrane. Finally, with the necessary  dependence on a distant 
relative for genetic and functional analyses, we wish to  estab- 
lish whether or not plasmid-encoded products in E. coli are 
identical to  their  native chlamydial counterparts. In this re- 
port, we demonstrate  that  the 82-kDa  protein (i) is associated 
with the  outer  membrane of both E. coli JM109(pPBW58), as 
well as C. trachomatis EB; (ii) the plasmid-encoded protein 
resembles its native counterpart in the properties of migra- 
tional  mass, isoelectric point,  antigenicity, and specific proteo- 
lytic  peptide profiles; (iii) these  properties  are consistent for the 
82-kDa  protein in the lymphogranuloma venereum (LGV) bio- 
variant of C. trachomatis; (iv) nucleic acid sequence analysis 
reveals that  the 82-kDa  protein is a relative of the  heat shock 
protein 70 (hsp70) family; and (v) the inferred primary amino 
acid sequence reveals  that  73 contiguous  amino  acids are 51% 
identical to  the surface-exposed Strongylocentrosus purpuratus 
receptor for sperm  binding (27). 
EXPERIMENTAL PROCEDURES 
Materials-Triton X-100, Nonidet  P-40,  N-lauroylsarcosine  sodium 
salt (sarcosyl), Polyoxyethylenesorbitan monolaurate (Tween 20) and 
ampicillin were obtained from Sigma. Proteases, protease inhibitors, 
and  protein  assay  reagents  were from Promega  and  Pierce  Chemical CO. 
Both prestained and unstained low molecular weight markers were 
from Bio-Rad. Carrier  ampholytes  were from Bio-Rad and  Pharmacia 
LKl? Biotechnology Inc. Nitrocellulose  membrane  for  immunoblotting 
was from Schleicher & Schuell.  Polyvinylidene  difluoride  (PVDF) mem- 
brane for protein sequencing was from Bio-Rad. Diethylaminoethyl 
(DEAEI-Sepharose Fast Flow and  high  resolution  Sephacryl  S-200  were 
from Pharmacia.  Rec-protein  G-Sepharose 4B was  from Zymed Labo- 
ratories, Inc. Restriction endonucleases, Ba131 exonuclease, T4 exo- 
nuclease 111, DNA ligase, T4 DNA kinase, Taq polymerase, Klenow 
fragment,  DNase  RQl,  RNase 1, 5-bromo-4-chloro-3-indolyl-/3-~-galac- 
topyranoside (X-gal), and isopropyl /3-o-thiogalactopyranoside (IPTG), 
were from Boehringer Mannheim and Promega. Electrophoresis re- 
agents  and  other  chemicals  were of a  high  purity  grade and obtained 
from several  standard  companies. 
Bacterial  Strains,  Plasmids, and Phage-C. trachomatis E/LTw-5/CX 
and LGV strain L2/434/Bu were  obtained from Drs. C. C. Kuo and S. P. 
Wang, University of Washington, Seattle. These strains were propa- 
gated in McCoy cells grown on microcarrier beads as  previously re- 
ported (28). EB were purified by Renografin density centrifugation, 
stored at -70 "C in  sucrose-phosphate-glutamate  buffer at a  concentra- 
tion of 1-2 x 1O'O particledml,  and  infectivity  was  determined  using 
McCoy cell monolayers  (29).  E. coli JM109  end  Al, rec Al,  gyr A96, thi, 
hsd R17  (rk-,mk+), re1 Al,  sup E44, A-, A(1ac-pro A B )  (F', tra D36, pro 
AB, lac IqZAM15) and plasmids pGEMBZA+) and pUC19, as well as 
helper  phage M13K07, were from Promega. Stock cultures  were  main- 
tained on M9 plates  supplemented  with 1 mM thiamine-HC1  and  ampi- 
cillin. E. coli transformants  were  grown  in  Luna  broth (LB) containing 
500 pg/ml ampicillin  after  selection on LB/ampicillin/X-gaYIPTG plates. 
Stock  cultures  were  maintained on M9  plates  supplemented  with 1 m~ 
thiamine-HC1  and  ampicillin. 
Subcellular  Fractions and Outer Membranes-One-liter cultures of 
mid-logarithmic  E. coli were  washed twice in phosphate-buffered  saline 
(PBS),  suspended  in 10 ml of  cold  20% (wh) sucrose in 0.03 M Tris-HC1 
(pH = 8.01, centrifuged at  4,000 x g for  10  min,  and  resuspended  in  25 
ml of cold 0.01 M MgCl2.HZO  to  induce osmotic shock. Following cen- 
trifugation,  supernatants  containing  periplasmic  components  were  dia- 
lyzed against  10 m~ Tris-HC1 (pH = 8.0)  and lyophilized. Cell pellets 
were  suspended  in  25 ml of cold 30 mM Tris-HC1,3 m~ EDTA (disodium 
salt,  pH = 7.3)  plus 1 mM phenylmethylsulfonyl fluoride (PMSF) and 
disrupted by five passages over a French pressure cell (1,600 p.s.i.). 
Clean,  crushed ice was  added  during cell disruption.  Debris  was pel- 
leted by centrifugation a t  2,000 x g for 10  min,  and  one-tenth of the 
resultant supernatants was centrifuged a t  47,800 x g for 15 min to 
pellet membranes and obtain supernatants containing cytoplasmic 
components. 
E. coli inner  and  outer  membranes  were  isolated  essentially as de- 
scribed by Ito  et  al.  (30). All ultracentrifugations  were  conducted  using 
a Sorvall T-865.1 rotor  (Du  Pont). Total membranes  were  clarified  from 
cell slurries by centrifugation through 15%/70% (w/v) discontinuous 
sucrose  gradients  in  the  presence of 3 m~ EDTA a t  50,000rpm for 30 
min (4 "C). Membranes  were collected at   the interface,  diluted  in  30 m~ 
Tris-HC1, 3 mM EDTA (pH = 7.3), and separated by centrifugation 
through  a 53%/70% (w/v) sucrose-EDTA gradient for 4 h at  50,000 rpm 
(4 "C). Inner  membranes  were collected above the 53% sucrose  interface 
and  outer  membranes collected above the 70% sucrose  interface. Mem- 
branes  were  washed in Tris-HC1 buffer  and  concentrated by centrifu- 
gation. All concentrated subcellular fractions were stored at -70 "C 
until  further  analysis. 
Chlamydial  outer  membrane complexes (COMCs) were  obtained by a 
modification of the procedure described by Bavoil et al. (31). Briefly, 
purified  EB  were  pelleted by centrifugation a t  13,000 X g for 10 min and 
resuspended  in  10 m~ sodium  phosphate  buffer  (pH = 7.4), 10 unitdm1 
DNase RQl  and RNase 1, and 0.2% (w/v) sarcosyl to a final volume 
resulting  in  a  2.5:l  detergent:protein  ratio.  The  suspension  was  incu- 
bated a t  37 "C for 30  min  with  several  short  sonications  in  a  Branson 
5200 bath sonicator. Sarcosyl-insoluble outer membrane complexes 
were pelleted and washed in phosphate buffer by centrifugation a t  
40,000 rpm for 1 h at 20 "C. Samples were immediately suspended 
either in solubilization buffer for sodium dodecyl sulfate-polyaclyl- 
amide gel electrophoresis (SDS-PAGE) analyses  or  in  fwation  solutions 
prior  to  processing  and  embedding  for  electron microscopic examina- 
tion. 
Enrichment of Protein by Ion Exchange-One-liter cultures of mid- 
logarithmic E. coli JMlOg(pPBW58)  were  washed twice in cold PBS  and 
resuspended  in  20  ml of 50 m~ Tris-HC1 (pH = 8.0).  Triton  x-100  was 
added  to a final  concentration of 1 mg:l  mg  (detergent:protein). Cell 
slurries  were  sonicated on ice 10  times  for  30 s each  with  a  Ultrasonics 
Incorporated W-385 probe tip  sonicator in  the presence of 1 mM PMSF. 
Following centrifugation at  4,000 x g for 15 min,  supernatants  were 
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incubated on a  rotator a t  4 "C for 30 to  45  min.  Triton X-100-insoluble 
material  was  removed by centrifugation a t  20,000 rpm for 15 min  at 
4 "C, and  the  supernatant  was loaded  onto  a  Pharmacia  C 16/40 column 
of DEAE-Sepharose  equilibrated  in  buffer  containing  50 mM Tris-HC1 
(pH = 8.0),  50 mM NaCl,  and  0.5% (v/v) Triton X-100. Following a  500-ml 
wash  with  the  initial  running buffer, a 200-ml linear  gradient of 50  to 
200 mM NaCl in  50 m~ Tris-HC1 (pH = 8.01, 0.5% Triton X-100 buffer 
was  initiated.  Fractions of 2  ml  were collected on a  Pharmacia  Frac-200, 
and since  Triton  interferes  with  ultraviolet  absorption  measurements, 
100 p1  of every  other  fraction  was  diluted 10-fold and  assayed for total 
protein  content.  Aliquots of 20 pl from every  other  fraction  were solu- 
bilized in  preparation  for  subsequent SDS-PAGE, Western  blotting  and 
two-dimensional PAGE analyses;  all  remaining  samples  were  frozen a t  
Protein Content and Electrophoretic Analyses-Total protein  content 
was  determined  using  the BCA Microassay  (Pierce)  with bovine serum 
albumin  as  a  standard.  Samples  containing  detergent,  although a t  lev- 
els below interference,  were  assayed  against  detergent-containing con- 
trols. Samples were prepared for SDS-PAGE (lo%, 12.5%, or 154  
PAGE) as described by Laemmli  (32), and  slab gels were  generated on 
a Hoefer SE 600 vertical  unit.  Protein  was  visualized by staining  with 
either  Coomassie  Brilliant  Blue R250 or  silver  as  described by Wray et 
al. (33).  Transfer to  nitrocellulose for Western  blotting  was  conducted 
overnight for 17 h at  80 mA in Towbin buffer  (34)  using a Hoefer TE 
series  Transphor  unit. In preparation for amino-terminal  sequencing by 
automated Edman degradation, polyacrylamide gels were allowed to 
polymerize overnight  and  0.1 mM thioglycolate  was  added  to the  upper 
running buffer. Protein  was  transferred  to PVDF membranes  in CAPS 
buffer as described by Matsudaira  (35).  Protein  bands  were  visualized 
and excised following staining  with  0.025%  (w/v) Coomassie Blue R-250 
in 40% methanol  and  destaining  with 50% methanol. 
For two-dimensional analyses involving isoelectric focusing in  the 
first dimension,  samples  were  suspended in 9 M urea, 4% (v/v)  Nonidet 
P-40, 2% (v/v)  6-mercaptoethanol,  a 2% (v/v)  ampholyte  mixture  (2:1, 
Bio-Rad:Pharmacia)  and  incubated at  room temperature for 2  h  prior to  
loading  (36).  Focusing  was  conducted for 17 h a t  700 V on a Hoefer GT 
2  tube  gel  unit,  and  the  anode  end of 11-cm tube  gels  was  marked  with 
2% (w/v)  Ponceau S. Tube gels  were  equilibrated for 30  min  in  0.125 M 
Tris-HC1 (pH 6.81, 2% (w/v) SDS, 10% (v/v) glycerol, 0.01% (w/v) brom- 
phenol  blue,  and  0.8%  (v/v)  p-mercaptoethanol  prior  to  running  in  the 
second dimension.  Internal  isoelectric  standards  were  initially  utilized 
for determination of isoelectric  points, but  interfered  with  migration of 
the  target  protein.  Therefore, isoelectric points  were  determined follow- 
ing  Western  analysis of two-dimensional  gels focused in a P 6  pH  gra- 
dient,  where  duplicate  tube g ls were  sacrificed, excised into  equivalent 
1.4-cm sections, dialyzed against deionized, distilled water, and pH 
measurements  obtained  according  to  a  previously  reported  method  (37). 
Migrational  distances  were  measured from the anode  end,  and isoelec- 
tric  points  established by simple  linear  regression  analysis. Total pro- 
tein profiles of two-dimensional  gels  were  obtained by silver  staining, 
except that following methanol  fixation, the  urea  content  was  reduced 
by washing  three  times for 10  min  each  in  generous  amounts of water. 
Samples for two-dimensional  diagonal  gel  analysis  were  prepared by 
suspension  in  100 m~ Tris-HC1 (pH 6.8),4% (w/v)  SDS, 6 M urea, 40 m~ 
iodoacetamide,  and 0.04% (w/v)  bromphenol  blue  and  incubated for 15 
min at 65 "C. Following electrophoresis of nonreduced  samples,  lanes 
were excised and  incubated  in  a  generous  amount of 50 m~ Tris-HC1 
(pH 8.81, 1%  (w/v)  SDS, and 3% (v/v)  P-mercaptoethanol at  65 "C for 15 
min. Gels were then equilibrated by three 50-ml washes in 50 mM 
Tris-HC1 (pH 8.8) and 0.1% (w/v)  SDS  and placed on a second dimension 
slab gel without  a  stacking gel. Subsequently,  silver-staining  and West- 
ern blot analyses  were  conducted. 
Polyclonal rabbit antiserum against C. trachomatis serovar E EB 
(anti-EB),  as well as  monospecific, polyclonal rabbit  antiserum  against 
the plasmid encoded protein (anti-82), were generated as previously 
described  (26).  IgG-concentrated  antisera  were  adsorbed five times for 
24 h against whole cells of E. coli JMlOS(pUC19)  prior to  dilution  in 
PBS-Tween 20 for Western blot analyses. A 1:2,500 dilution of the 
anti-82  serum  and a 1:200  dilution of the  anti-EB  serum  was  used  in  the 
primary  incubation  step following blocking with 2.5% gelatin  in  PBS- 
Tween 20. Alkaline  phosphatase-conjugated  goat  anti-rabbit I g G  
(Sigma)  was  used for detection (38). Immunoreactive  proteolytic  peptide 
profiles  were  obtained  using the  Protein  Fingerprinting  System  avail- 
able from Promega.  Digestion  with  endoproteinase Glu-C and  endopro- 
teinase Lys-C was  conducted as described by the  manufacturer,  but  due 
to limited quantities of native chlamydial protein, Western analyses 
were  substituted for staining. 
I)-ansmission  Electron Microscopy-Sarcosyl-insoluble COMCs were 
-70 "C. 
(i) fixed in 2% glutaraldehyde, 0.5% paraformaldehyde  and processed 
for embedding in Epon-Araldite resin for morphological examination 
and  (ii) fixed in  0.05%  glutaraldehyde, 2.0% paraformaldehyde at 4 "C 
and processed for  embedding in  ultraviolet  photopolymerizing LOwiCryl 
K4M resin a t  -20 "C to  preserve  antigenicity for post-embedding im- 
munogold labeling  (24).  Because  the  number of exposed antigenic  epi- 
topes in  the chlamydial  membrane  environment  is  limited  within  each 
ultrathin  section,  the  anti-82  serum  was  utilized a t  a  0.5 mg/ml con- 
centration in 1% (w/v) ovalbumin, 0.01 M glycine in PBS (pH = 7.4). 
Primary  anti-82  antibodies  were  detected  using  30-nm gold-conjugated 
secondary goat anti-rabbit IgG (Auroprobe,  Amersham  Cow.).  Ultra- 
thin sections  were  stained  with  uranyl  acetate  alone, or with  uranyl 
acetate  and  lead  citrate,  and  examined on a  Phillips  201  electron mi- 
croscope operating a t  60 kV. 
DNA Sequencing-All genetic  manipulations  were conducted by 
standard  methods  (39).  The  open  reading  frame  (ORF) for the  82-kDa 
protein was located a t  one end of the 6.7-kb insert in pPBW58 by 
deletion  mutagenesis  andWestern blot analysis.  E. coli 
JMlOS(pPBW116) contains a 2.2-kb insert,  encompassing  the  82-kDa 
ORF, in  the  multiple cloning site of pGEM3Zff +). Single-stranded DNA 
template of the coding strand  was  obtained from this subclone following 
coinfection with M13K07 helper phage. Additionally, nested deletion 
subclones of pPBW58 were  generated  using  exonuclease 111, and  tem- 
plates for both strands were  obtained from double-stranded DNA.  Tem- 
plates  were  primed  with oligonucleotides complimentary  to vector se- 
quence  flanking  the  chlamydial  DNAinsert,  and  several oligonucleotide 
primers were synthesized according to known sequence to span and 
overlap the ORF. Sequencing by the dideoxy chain  termination  method 
was conducted using both the TaqTrack deazanucleotide sequencing 
system by Promega  and  the  Sequenase kit by U. S. Biochemical Corp. 
Sequencing  reactions  were  separated by electrophoresis on 5  and 6% 
polyacrylamide, 8 M urea gels using an IBI  Base  Runner  apparatus from 
International Biotechnologies, Inc. Sequence from both strands was 
assembled  and  analyzed  using  the Wisconsin Genetics  Computer  Group 
(GCG)  software  package  and  the  Lasergene  software  system by DNA- 
STAR for the Apple Macintosh  (system  7.0).  Data  base  searches  were 
performed by  FASTA and TFASTA programs  in  the  GenBank  (release 
76.01, EMBL (release 26.01, and SwissProt (release 25.0) data base 
libraries. 
RESULTS 
Antiserum Specificity-Immunodetection of the plasmid-en- 
coded 82-kDa protein in E. coli JM109(pPBW58) is accom- 
plished using polyclonal antiserum  generated  against whole C. 
trachomatis serovar E  EB (anti-EB).  In  order to examine the 
native  counterpart in  chlamydial EB by comparable  methods, 
monospecific polyclonal antiserum was generated  using elec- 
troeluted 82-kDa protein from preparative, one-dimensional 
SDS-polyacrylamide slab gels of total E. coli JM109 (pPBW58) 
lysates  as  an  antigen  (anti-82). Although this  preparation con- 
tained the plasmid-encoded protein, a native E. coli protein 
having similar migrational properties was present in nearly 
equimolar amounts. A more comprehensive profile of antigenic 
reactivity  was  obtained following two-dimensional electropho- 
retic separation  and Western  blotting  (Fig. 1). The  anti-82 se- 
rum detects two proteins  in E. coli JMlOg(pPBW58): the plas- 
mid-encoded product  (Fig. X ,  arrow), which was confirmed by 
reactivity with the anti-EB serum on duplicate blots, and a 
separate  native E. coli protein of a  slightly more acidic nature 
(Fig. lC, arrowhead). Only one chlamydial protein species is 
detected  using the  anti-82  serum (Fig. 1 D ,  arrow). This protein 
is not unique to C. trachomatis serovar E; Western analysis 
indicates a homologous counterpart  is  present  in LGV and dis- 
tantly  related Chlamydia  psittaci (26). 
These analyses were also conducted within a narrow pH 
range of 4.0-6.5 (data not  shown). Regression analysis of the 
pH gradient  standard curve  (correlation coefficient = 0.99) des- 
ignates a PI value of 5.38 for the protein in C. trachomatis 
serovar E, and a PI  value of 5.32 for the plasmid-encoded prod- 
uct. The relative migrational value for the plasmid-encoded 
protein,  as  assessed by SDS-PAGE and by elution  properties 
over a Sephacryl S-200 gel filtration column (data not  shown), 
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JM109(pPRW58) ( A  and C)  and C. trachomatis serovar  E EB ( R  and D )  were focused in a 3-10 pH range in the  first dimension and separated by 
FIG. 1. Total protein profiles and specificity of antiserum by two-dimensional PAGE. 20 pg of total cell protein from E. coli 
SDS-PAGE in the second dimension.  Gels  were  stained  with  silver for visualization of total  protein ( A  and B )  or transferred to nitrocellulose for 
immunoreactivity  with the  anti-82  serum (C  and Dl. Arrows indicate the position of the plasmid-encoded protein ( A  and C )  and  the respective 
native  protein  in C. trachomatis ( B  and D). The open arrowhead indicates  antigenic  reactivity  with  a  native  E. coli protein of similar  mass (C).  The 
insets (C and D )  are photographic  enlargements of the  antigenic regions. 













FIG. 2. Analysis of subcellular fractions of E. coli 
JM109(pPBW58). Approximately 15-20 pg of total protein in each 
sample was resolved by SDS-PAGE and visualized by staining with 
Coomassie Blue ( A )  or examined by Western blot analysis  using  the 
anti-EB  serum ( B ) .  Samples include: total cell lysates of E. coli 
JMlOS(pUC19) as  a  negative control (lanes 1 ), total cell lysates  ofE. coli 
JM109(pPBW58) (lanes 2 ) ,  E. coli JM109(pPBW58) cytoplasmic frac- 
tion (lanes 3 ) .  E. coli JM109(pPBW58)  periplasmic  fraction (lanes 4 ) ,  E. 
coli JM109(pPBW58)  inner  membranes (lanes 5 ) ,  E. coli 
JM109(pPBW58)  outer  membranes (lanes 61, and  E. coli 
JM109(pUC19)  outer  membranes for comparison (lanes 7). Arrowheads 
indicate  the  migrational position of the  intact  protein. 
is  approximately 82 kDa (t 7 kDa).  These  studies show that  the 
anti-82  serum  is highly monospecific for the chlamydial  protein 
and  represents  an excellent probe for subsequent immunode- 
tection analyses. 
Outer  Membrane Association-For a molecule to  participate 
in  an  attachment mechanism, or actually serve as  an adhesin, 
an  external location in  the envelope is reasonably expected. We 
chose not  to  pursue surface-labeling techniques with "'1 for 
two reasons: (i) purification procedures for EB result in as 
much as  5% damaged  particles which may create a wide mar- 
gin of error  (12),  and  (ii) I2'I labeling is  detrimental  to chla- 
mydial infectivity. Using the anti-82 serum, immunofluores- 
cent microscopic examination of intact E. coli JM109(pPBW58) 
and C. trachomatis EB showed no significant  reactivity above 
background. This  result  is  not  surprising since the  serum  was 
generated against a denatured antigen, which substantially 
decreases  the likelihood of recognition of a protein in  its  native 
configuration (40). SDS-PAGE and Western analysis of E. coli 
JMlOg(pPBW58)  subcellular fractions show the 82-kDa  protein 
present  in both the cytoplasm and isolated outer  membranes 
(Fig. 2B, lanes 3 and 6,  respectively).  Proteolytic fragments  are 
also  present  in  the  inner  membrane fraction  (Fig. 2B, lane 5 ) .  
The rigid structural organization of chlamydial EB  has,  to 
date,  prevented fractionation into  subcellular  compartments by 
standard approaches. However, COMCs are isolated by suspen- 
sion of EB  in sarcosyl detergent  and incubation a t  37 "C with 
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FIG. 3. Analysis of sarcosyl-soluble and -insoluble fractions of 
C. trachornatis. 20 pg of total  protein  in each sample  was resolved by 
SDS-PAGE and visualized by staining  with Coomassie Blue (lanes 1 3  
and 7-9) or examined by Western blot analysis  using  the  anti-82  serum 
(lanes 4-6 and 10-12). Both C. trachomatis serovar  E (lanes 1-6) and 
LGV serovar L2 (lanes 7-12) are shown. Samples include: purified 
intact  EB (lanes 1,4, 7, and lo), sarcosyl-soluble extracts from purified 
complexes from purified EB (lanes 3, 6 ,  9, and 22 ). 
EB (lanes 2, 5 ,  8, and 11 ), and sarcosyl-insoluble outer membrane 
intermittent sonication. This technique has been employed for 
enrichment of the 40- and 60-kDa cysteine-rich chlamydial 
outer  membrane  proteins  (20,  31). Using both C. trachomatis 
serovar E EB (Fig. 3, lanes 1-43) and LGV serovar L2 EB (Fig. 
3, lanes 7-12), Western  blots using  the  anti-82  serum  (Fig. 3, 
lanes 4-6 and 10-12) demonstrate  that not only the subcellular 
location, but also the distribution, of the 82-kDa protein is 
similar to that observed in E. coli JMlOg(pPBW58). As previ- 
ously shown in Fig. 1, the  antiserum  reacts with only one pro- 
tein species in chlamydial EB. Therefore, the  smaller antigenic 
fragments  in Fig. 3  most likely result from an unknown endog- 
enous proteolytic activity. Another possibility, which may in- 
clude  activation of a protease, is heat-induced  degradation of 
the 82-kDa protein. It is well established  that exposure of chla- 
mydial EB to heat decreases infectivity (20,42). For C. tracho- 
matis serovar D EB, a  15-min  incubation in PBS a t  a  tempera- 
ture of only 37 "C decreases infectivity of the inoculum to  less 
than 20% (42). The specific pattern of degradation in both C. 
trachomatis serovar E  (Fig. 3, lane 5 )  and LGV serovar L2 (Fig. 
3, lane 11 ) infers  that  this protein is conserved at  the level of 
primary  amino acid sequence in these otherwise pathogenically 
diverse  biovariants. 
Because of the  rapid  degradation of the 82-kDa protein fol- 
lowing cell disruption, topological studies  using specific prote- 
ases have not been pursued. However, to provide additional 
evidence that  this protein is associated with the chlamydial 
outer  membrane, immunolocalization by transmission electron 
microscopy was conducted (Fig. 4). COMC pellets  were fixed, 
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FIG. 4. Immunodetection of the 82-kDa protein in COMCs by 
transmission electron microscopy. Sarcosyl-insoluble outer mem- 
brane complexes from purified C. trachomatis serovar E EB were pro- 
cessed and embedded in  Epon-Araldite for morphological examination 
(panel  A )  and processed and embedded in Lowicryl K4M for post-em- 
bedding  immunolabeling of the 82-kDa protein with the anti-82 serum 
and  30-nm colloidal gold-conjugated  second  affinity antibodies (panels  
B-D). Magnifications for each panel are as follows: A, x 30,000; B ,  x 
20,000; C, x 70,000; D, x 100.000. 
processed  and  embedded by two  separate  procedures;  one proc- 
ess emphasizes  contrast  and  resolution  for morphological ex- 
amination (Fig. 4A ), and  the second  method  employs  mild  fixa- 
tion and a low temperature embedding process to preserve 
antigenicity (Fig. 4, B-D). As  shown,  COMCs  are specifically 
labeled by the  anti-82  serum,  and  the  majority of immunod- 
ominant  epitopes  appear  to  be  located on the  inner  surface of 
the  outer  membrane.  Thin  sections  were  also  incubated  with 
second affinity gold-conjugated antibodies only, as a control, 
and  no nonspecific labeling  was  observed. 
Enrichment of the Plasmid-encoded Protein from E. coli 
JM109(pPBW58)-As presented  in  Fig.  1, a native E. coli pro- 
tein of similar  mass  and  shared  immunogenicity  was  expressed 
in  nearly  equimolar  amounts as the plasmid-encoded  product. 
For  amino  acid  analyses  and  immunoanalyses at  the  primary 
structural  level,  it  was  necessary  to  separate  these molecules. 
Additionally,  with a n  extended  commitment  to  eventually  pu- 
rify the protein for structure-function analyses, a mild ap- 
proach  was  initiated  utilizing  non-ionic  detergents for solubil- 
ity  and ionic strength  for  separation.  Although  the  cytoplasmic 
form of the  82-kDa  protein  was  soluble  in  most  aqueous  envi- 
ronments,  the  membrane-associated  form  was  insoluble  in  sev- 
eral non-ionic detergents  within a 0.1:l  to 1O:l detergent: 
protein  ratio. However, a 1:l  detergent:protein  ratio of Triton 
X-100 was  found  to effectively bring  the  membrane  form of the 
protein  into  solution  from  either  isolated  membranes or total 
cell lysates.  The  protein  then  remained  soluble  in a 0.5% Triton 
X-100,50 mM NaCl,  50 mM Tris-HC1 environment.  DEAE  anion 
exchange  chromatography,  employing a 50-200 mM NaCl con- 
tinuous  elution  gradient,  separated  the  plasmid-encoded prod- 
uct  from  other  proteins of similar  mass  (Fig. 5). This  approach 
resulted  in a 40-fold enrichment of the  82-kDa  protein from 
initial whole cell preparations of E. coli JM109(pPBW58).  Elu- 
tion of the plasmid-encoded  protein at 135 mM NaCl  was con- 
sistent  regardless of whether  the  starting  materials  were ( i )  
total cell lysates,  (ii)  cytoplasmic  extracts, or (iii)  isolated  outer 
membranes.  The  predominant  native E. coli protein  eluted a t  
185 mM NaCl. For a more comprehensive evaluation of the 
effectiveness of separation, two-dimensional PAGE analyses 
showed the exclusive  presence of the  82-kDa  protein  within  an 
approximate  30-kDa  migrational  range  (Fig. 5, D,  arrow, 
DEAE fraction 54), whereas several other E. coli 60-90-kDa 
proteins  were  present  in  DEAE  fraction  86  (Fig. 5E ). Degrada- 
tion of the  82-kDa  protein  occurred  concomitant  with cell dis- 
ruption,  and  to  date, we have  been  unable  to  arrest  this  process 
using  several  combinations of standard  proteolytic  inhibitors. 
Preliminary  studies  indicate  the  82-kDa  protein is ot  autopro- 
teolytic  (data  not  shown);  this  is  supplemented by the  observa- 
tion that, following elution from DEAE, there is no further 
degradation of the  protein. 
Proteolytic Profiles-Peptide profiles  were  generated by par- 
tial  proteolytic  digestion  to  examine  the  degree of relatedness 
between  the  plasmid encoded 82-kDa  protein  and  its  natural 
chlamydial counterpart. Since the native chlamydial protein 
cannot  be  obtained  in  large  quantities,  antigenic profiles were 
substituted  in  the  place of protein  staining  for  increased  sen- 
sitivity. The  resultant  ladder of antigenic  proteolytic  fragments 
from  the  chlamydial  protein, following digestion  with endopro- 
teinase Glu-C and  endoproteinase Lys-C, is schematically  out- 
lined  to  the  right  ofeach  Western  blot  (Fig.  6).  The  predominant 
E. coli 82-kDa  protein  from  DEAE  fraction  86  was  included for 
comparison (Fig. 6,  lanes 1 ). This  protein  differs from the  chla- 
mydial  protein  in  primary  sequence  organization.  The  plasmid- 
encoded  protein  in  DEAE  fraction  54  (Fig.  6,  lanes 2 )  is  iden- 
tical  to  its  natural  counterpart  in  both C. trachomatis  serovar 
E EB  and LGV serovar L2 EB  (Fig.  6,  lanes 3 and 4, respec- 
tively). 
Disulfide Linkage-Since several  outer  membrane  proteins 
of the  chlamydiae  are  unusually  cysteine-rich  and  highly  cross- 
linked, we investigated  potential  disulfide  interactions for the 
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lytic profiles. Antigenic proteolytic fragments of the 82-kDa proteins 
FIG. 6 .  Examination of protein relatedness by partial  proteo- 
were visualized by Western blot analysis following digestion with 1:l 
(protease:protein)  endoproteinase Glu-C (A 1, 1:l endoproteinase Lys-C 
( B ) ,  and 1O:l endoproteinase Lys-C ( C ) .  E .  coli protein from DEAE 
fraction 86 (lanes I )  is shown for comparison. The plasmid-encoded 
protein from DEAE fraction 54 (lanes 2 )  was evaluated against the 
native protein from C. trachomutis serovar  E  EB (lanes 3 )  and LGV 
serovar L2 EB (lanes 4 ) .  Proteolytic fingerprints  are  schematically rep- 
resented to  the right of each blot for clarity. 
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electrophoresis. 20 pg of total  protein from DEAE fraction 54, repre- 
FIG. 7. Investigation of disulfide linkages by  two-dimensional 
senting  the plasmid-encoded protein (A and B ), and from C. trachomatis 
serovar E EB ( C  and D )  was  subject  to  electrophoresis  under nonreduc- 
ing conditions in the  first  dimension  and reduced prior to separation  in 
the second dimension. Total protein  was visualized by silver  staining (A 
and C ) ,  and  the  82-kDa  protein  was specifically highlighted by Western 




tially  dimerizes  with  itself  (Fig.  7, A and B ); other  proteins of a 
separate  origin are not  cross-linked  to  the  82-kDa  protein  in E. 
coli JMlOg(pPBW58). The protein  in C. trachomatis serovar E 
EB appears to be exclusively monomeric (Fig. 7, C and D). 
Dimerization of the plasmid-encoded protein may therefore 
represent a solubilization  artifact.  Nonetheless,  no  other pro- 
tein  appears  to  be  covalently  linked  to  the  82-kDa  protein by 
disulfide  bonding. 
Sequence Analyses-The ORF for the 82-kDa protein was 
localized to a 2.2-kb HincII  fragment at one  end of the pPBW58 
insert  (Fig. &I). Localization  was  accomplished by deletion  mu- 
tagenesis, followed by examination of resultant  subclones for 
expression of the  intact  protein by Western  blot  analysis. To 
confirm the start of the ORF, a preparative gel of DEAE frac- 
tion  54  was  electrophoretically  transferred  to  PVDF  membrane 
to obtain an amino-terminal amino acid sequence (Fig. 8B). 
Sequence  analysis of the  ORF  indicates  that  the  82-kDa  protein 
is a relative of hsp70.  At  the  nucleotide level, the 1879-bp C. 
trachomatis serovar E hsp70  ORF  has:  (i) 97.9% identity  with 
C. trachomatis serovar D hsp7O (43), (ii) 99.8% identity  with 
JM109(pPBW58) by DEAE chromatography. The Triton X-100- 
FIG. 5. Enrichment of the 82-kDa protein from E. coli 
soluble  material from mid-logarithmic E.  coli JMlOg(pPBW58)  was  ap- 
plied over a DEAE-Sepharose column and  samples collected throughout 
a 50-200 mM linear  gradient of NaCl as  described under  "Experimental 
Procedures." The elution profile ( A )  was visualized following SDS- 
PAGE by Coomassie staining ( B ) ,  and the plasmid-encoded 82-kDa 
protein  was  identified by immunoreactivity  with the  anti-EB  antiserum 
by Western  blotting ( C ,  arrows, and * indicates  degradation).  The ef- 
fectiveness of isolation  was  examined by two-dimensional PAGE and 
silver staining; DEAE fraction 54 (D) contains the plasmid-encoded 
protein (arrowhead), and DEAE fraction 86 ( E )  contains the native 
immunogenic E. coli protein of a similar  mass (open  arrowhead). The 
insets (D and E )  are photographic  enlargements of the proteins. 
82-kDa  protein  in  both E. coli JM109(pPBW58)  and C. tracho- 
matis serovar E EB (Fig.  7).  DEAE  fraction  54  was  examined  n
order  to  eliminate  signals  from  the  other E. coli antigenic  pro- 
tein. The plasmid-encoded protein is monomeric and poten- 
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The  82-kDa  ORF  was located a t  one  end of the pPBW58 C. trachomatis 
FIG. 8. Location of the 82-kDa ORF and nucleic acid sequence. 
serovar E DNA insert by deletion  mutagenesis  and  Western  analysis; 
tional  direction, A).  Abbreviations are as follows: B,  BamHI;  H,  HincII; 
pPBW116 was  utilized for sequence  analysis (arrow indicates  transcrip- 
and E ,  EcoRI. The nucleic acid sequence is presented in B ,  and  the 
derived  amino acid sequence is shown  underneath  nucleic acid residues. 
in closely related C. trachomatis  serovar D hsp7O. Carboxyl-terminal 
Bases that  are doubly  underlined  indicate an  insert region  not  present 
bases that  are  underlined  are  vector-derived. 
LGV serovar L2 hsp70 (441, (iii) 77.1% identity with Chlamydia 
pneumoniae hsp70 (451, (iv) 88.9% identity over a 747-bp region 
with C. trachomatis mouse pneumonitis hsp7O (46), and (v) 
40.5% identity over a 1344-bp region with E. coli DnaK (47). 
Relatedness between the  serovar D and  serovar E hsp70s  was 
substantiated by immunoblot analysis using anti-serovar D 
hsp70 sera kindly provided by Dr. Rosanna Peeling. 
180 190 
IPEPTAAALAYGIDKEGDKKKI - c. trachanotis serwor E hv70 
VISDTTAVALAYGIYKQ~ - s. ourouratus spem receptor 
FIG. 9. Comparison  of the C. trachornatis hsp7O inferred amino 
acid sequence with the S.  purpuratus sperm receptor binding 
domain. Identical  residues  are  indicated by a vertical line,  and  resi- 
dues  in bold type represent the chlamydial immunodominant T-cell- 
stimulating  peptide  region. 
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The serovar E sequence contains a 27-nucleotide insert  re- 
gion from residue 700 to 726 (Fig. 8B, double underline), which 
is  not  present in serovar D  hsp70 but is present  in LGV serovar 
L2  hsp7O. Transcription is presumably initiated from upstream 
chlamydial  sequence  (Fig. 8A, arrow), and a serviceable ribo- 
some binding site  is  present 7-11 bp in  front of the ATG start 
codon (Fig. 8B). The  translated product contains 14 non-chla- 
mydial  amino  acids in  the carboxyl terminus, which is 16  resi- 
dues  short of the predicted native chlamydial  protein  (Fig. 8B, 
single underline). Sequence analysis of the  entire 6.7-kb chla- 
mydial insert  in  adherent E. coli JM109(pPBW58), to include 
(i) analysis of promotor regions, (ii) genomic organization of 
ORFs, and (iii) molecular characterization of the other ex- 
pressed  chlamydial  proteins, will be reported  elsewhere. 
Although we have provided nucleic acid sequence data for 
the previously unknown 82-kDa protein, the  emphasis of our 
investigation is  to eventually ascertain  whether or not hsp7O 
plays a role in mediating attachment. We therefore wish to 
highlight structural implications from the inferred  amino acid 
sequence. We have  demonstrated  an  outer  membrane location 
for the chlamydial hsp7O; previous reports on other chlamydial 
hsp7O proteins  have  either presumed that  the subcellular lo- 
cation is exclusively cytoplasmic (44) or have  not examined the 
possibility of membrane association at all. Zhong and  Brunham 
(48)  have identified two immunodominant peptide  regions  in 
LGV serovar L2 hsp70, which suggests surface accessibility; 
one of these regions (G-R-I-A-G-L-D-V-K-R) was found to 
stimulate proliferation of primed T-cells. This peptide region is 
conserved in  the C. trachomatis serovar E hsp7O sequence  (Fig. 
9, residues 161-170, bold type). Finally, with the recent  finding 
that  the  external receptor-binding  domain for sperm  in S.  pur- 
puratus is homologous to  human hsp7O (27), we compared our 
sequence  with this domain. As shown in Fig. 9, a striking 37 
amino acid residues  within a 73-amino acid stretch  are  identi- 
cal to  the receptor  binding  domain. Of the  remaining 36 resi- 
dues, 11 are chemically similar  residues.  In addition, the T-cell- 
stimulating,  immunodominant peptide is encompassed within 
this region. 
DISCUSSION 
Our previous work resulted  in  the selection of an  adherent 
chlamydial recombinant, E. coli JM109(pPBW58), which at- 
taches to  human  endometrial  epithelial cells in  a highly specific 
manner resembling chlamydial EB (26). This approach was 
first employed by Isberg  and Falkow (49)  and led to the iden- 
tification of the Yersinia  pseudotuberculosis invasin gene. E. 
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coli JM109(pPBW58)  expresses at least  three proteins, which 
are encoded from the 6.7-kb C. trachomatis  serovar E  contigu- 
ous genomic insert in vector pUCI9. One protein is approxi- 
mately 82  kDa (* 7 kDa)  and was originally identified by reac- 
tivity with anti-EB polyclonal antisera. In this report, we 
demonstrate that this protein is associated with the outer 
membrane in  both  recombinant E. coli JMlOg(pPBW58) and  in 
native chlamydial  EB using a  highly monospecific polyclonal 
antiserum  as a probe. We also conducted some of these  analyses 
on the homologous protein in LGV, the C. trachomatis biovari- 
ant  that  causes  an invasive disease syndrome leading to lymph- 
adenopathy. In  contrast, C. trachomatis serovars D-K differ by 
remaining localized in  the epithelial  lining of the  genital mu- 
cosae. The 82-kDa  protein from LGV was  also outer  membrane- 
associated. Enrichment of the plasmid-encoded protein pro- 
vided an amino-terminal sequence, which expedited locetion 
and identification of the ORF. The isolated protein and the 
monospecific antiserum were employed in  partial proteolytic 
mapping  analyses,  the  results of which indicate  the plasmid- 
encoded protein is  similar to its  native  counterpart  in C. tru- 
chomatis EB. Nucleic acid sequence analysis of the ORF indi- 
cates  this protein is  related  to  the hsp70 family of proteins. 
Chlamydial hsp7O ORFs have been sequenced in  other bio- 
variants  and  serovariants of C. trachomatis  (43,44,46),  as well 
as  in  other species (45),  but  the functional roles of these pro- 
teins  in  the chlamydiae have not been thoroughly investigated, 
partly due to technical limitations. However, an  elegant  series 
of studies by Brunham, Peeling, and associates (43,48, 50-52) 
have implicated an important role for hsp70 in immunity 
against chlamydial infections. In  patient  studies,  certain im- 
munodominant  chlamydial antigens were  correlated  with pro- 
tective or destructive immunopathological disease processes 
(50). One of the protective antigens, antibodies to which were 
able to  neutralize chlamydial infectivity, was  identified as  the 
C. trachomatis “DnaK-like”  protein (43, 48). Their studies 
would suggest surface accessibility of the chlamydial hsp70, 
and,  in  this  report, we are  able  to  demonstrate  that, indeed, 
hsp7O has  an  external location in  the envelope. These results 
were  somewhat surprising  to us because they  represent a de- 
viation from the  traditional roles assigned to DnaK in  the cy- 
toplasm, such  as  the folding of newly synthesized polypeptides 
(531, participation  in  the  regulation of gene  expression  (54,551, 
and association with,  and  presentation of, abnormally folded 
proteins to the cellular proteolytic machinery  (56). The careful 
designation of “DnaK-like” emphasizes not only the 61%  iden- 
tity  with  the  first four-fifths of E. coli DnaK at the amino acid 
level, but also the  less  than 34% identity with the  last one-fifth 
of the molecule. There  is some evidence that  this  latter domain 
in mammalian hsp7O specifies compartmentalization within 
the cell (57). Furthermore, why would an hsp70 molecule pre- 
dominate  in  the  translationally inactive, infectious EB form of 
Chlamydia? Given the small genomic size of C. trachomatis 
(1,450 kb; Ref. 581, the  estimated  number of molecules encoded 
would be less  than half the  number of molecules expressed by 
mid-logarithmic E. coli (59,  60).  Therefore, it  seems  plausible 
that individual  chlamydial  products may  participate  in more 
than one function. Perhaps  the cytoplasmic configuration  func- 
tions  in traditional roles  assigned to DnaK, whereas a separate 
configuration is found in  the envelope. It  is  clear  that we are at 
the  stage of characterizational  analyses; our goal is to eventu- 
ally establish  the functional  role(s) of the envelope-associated 
chlamydial hsp7O. 
The subcellular localization analyses  are  perhaps  the most 
significant  aspect of this  study; however, demonstration of the 
relatedness between the plasmid-encoded and  native protein 
by antigenicity, mass, charge, and proteolytic profiles cannot be 
underestimated. Molecular analyses of the chlamydiae at a 
genetic level are limited  due to  the lack of a  genetic system. E. 
coli is often employed as a surrogate genetic host,  and  although 
much information has been obtained by this approach, many 
chlamydial  products are  not expressed  in E. coli. It  is commonly 
speculated that some ORFs are behind unique chlamydial pro- 
motors,  not recognizable by the E. coli transcriptional machin- 
ery, and  it  is also possible that some chlamydial  products are 
toxic to E. coli. Certainly, the rigid cysteine-rich chlamydial 
outer  membrane proteins, if cross-linked in E. coli following 
expression and translocation, would give rise  to considerable 
steric problems and prevent cell division. Finally, because of 
the dependence  upon E. coli, codon usage  may differ between 
such  diverse  organisms. 
In  relation to the  adherent phenotype of E. coli 
JM109(pPBW58), we believe the contributions of chlamydial 
hsp7O may be indirect or direct. The possibility that chlamydial 
hsp7O does not a t  all  participate  in  attachment  has not been 
overlooked. This molecule may actually assume an envelope 
location for easy access in order to function in subsequent 
events following attachment. Very little  is known about  trans- 
location or secretion of proteins in chlamydial RB. In addition, 
the source of the expanding  chlamydial inclusion membrane 
remains a  mystery; thus, the possibility that chlamydial mol- 
ecules  have access to  intracellular components of the  host cell 
can not be ruled out. Bovine hsp7O has been shown to possess 
clathrin-uncoating activities  (61).  This  may constitute a likely 
area of investigation  since the chlamydiae are  internalized by a 
receptor-mediated pathway involving clathrin-coated pits (23- 
25). Additionally, it  is known that highly conserved hsp7O  poly- 
peptide  regions copurify with  intermediate  filaments  and mi- 
crotubules (62). This  may  implicate an  intracellular  structural 
role for hsp70, perhaps  related  to  the perinuclear location as- 
sumed by the developing chlamydial inclusion. 
Hultgren and colleagues (63) have recently summarized 
many  years of investigation leading  to a model for presentation 
of the P pilus adhesin of uropathogenic E. coli by molecular 
chaperones. Although we have demonstrated that the chla- 
mydial hsp7O is not covalently linked to other proteins, it  is 
possible that  this protein participates  in  an analogous, indirect 
role, which is nonetheless crucial for adhesin presentation. 
ATPase activity is a common theme for hsp70 proteins from 
diverse  origins, and  an  intrinsic ATPase activity has been  de- 
tected  in the inert chlamydial EB by high  resolution 31P 
nuclear  magnetic  resonance  (64). If this activity originates from 
hsp70,  it may provide the energy  necessary for the induction of 
a conformational change on the  EB surface, thus  making  at- 
tachment molecules accessible to host cell receptors in a coor- 
dinated  attachment event. 
Evidence for direct  participation of an  hsp7O-like protein in 
an  external  attachment process between two separate  entities 
has  not been established until recently. After  a  30-year search 
for the receptor  binding  domain for sperm, Foltz et al. (27, 65) 
have found that the domain has sequence homology to the 
hsp7O family of proteins. We were intrigued to find that a 
contiguous 73-amino acid region of the 6. trachomatis serovar 
E  hsp70 is 51% identical to  the receptor  binding domain. In- 
terestingly, this region encompasses the T-cell-stimulating,  im- 
munodominant  epitope in C. trachomatis previously described 
by Zhong and  Brunham (48). 
We are encouraged by the  results  presented  in  this  report; 
however, a direct assessment of function awaits  the purification 
of chlamydial  hsp70, which may be possible by an ATP chro- 
matographic step since hsp70 proteins possess an  inherent af- 
finity for ATP (66). Purification of not only hsp70,  but each of 
the other proteins encoded by E. coli JM109(pPBW58), and 
examination of their  participation in a functional assay may 
C. trachomatis  hsp70 Protein in Outer Membrane 23147 
provide  new insights on  chlamydial attachment or internaliza- 
tion  mechanisms.  This goal, concomitant with  an  evaluation of 
deletion mutants of E. coli JMlOg(pPBW58) in  the functional 
attachment  assay,  is  under way. 
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